Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-in Capital	Treasury Stock		Retained Earnings	Accumulated Other Comprehensive Income	Non- Controlling Interests
Balance, beginning of period at Dec. 31, 2023		$ 5,332,286	$ 1		$ 3,068,597	$ (1,265,097)		$ 3,510,544	$ 896	$ 17,345
Balance, beginning of period (in shares) at Dec. 31, 2023			106,917,636
Balance, beginning of period (in shares) at Dec. 31, 2023						54,211,879
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		191,161						190,270		891
Exercise of stock options and issuance of restricted stock units, net (shares)	[1]		633,766
Exercise of stock options and issuance of restricted stock units, net	[1]	$ (10,856)			(10,856)
Repurchase of common stock (shares)		(1,491,485)	(1,491,485)			(1,491,485)
Repurchase of common stock		$ (91,649)				$ (91,649)
Stock compensation expense		5,483			5,483
Distributions to non-controlling interests of consolidated joint ventures		(257)								(257)
Balance, end of period at Mar. 31, 2024		5,426,168	$ 1		3,063,224	$ (1,356,746)		3,700,814	896	17,979
Balance, end of period (in shares) at Mar. 31, 2024			106,059,917
Balance, end of period (in shares) at Mar. 31, 2024						55,703,364
Balance, beginning of period at Dec. 31, 2024		5,878,180	$ 1		3,086,342	$ (1,616,170)		4,393,853	2,509	11,645
Balance, beginning of period (in shares) at Dec. 31, 2024			102,241,978
Balance, beginning of period (in shares) at Dec. 31, 2024						59,819,731
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		213,731						213,466		265
Exercise of stock options and issuance of restricted stock units, net (shares)	[2]		534,036
Exercise of stock options and issuance of restricted stock units, net	[2]	$ (5,663)			(5,663)
Repurchase of common stock (shares)		(2,243,995)	(2,243,995)	[3]		(2,243,995)	[3]
Repurchase of common stock	[3]	$ (136,116)				$ (136,116)
Stock compensation expense		7,785			7,785
Distributions to non-controlling interests of consolidated joint ventures		(393)								(393)
Balance, end of period at Mar. 31, 2025		$ 5,957,524	$ 1		$ 3,088,464	$ (1,752,286)		$ 4,607,319	$ 2,509	$ 11,517
Balance, end of period (in shares) at Mar. 31, 2025			100,532,019
Balance, end of period (in shares) at Mar. 31, 2025						62,063,726

[1] (1) Dollar amount includes $4.0 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.

[2] Dollar amount includes $5.2 million of stock options exercised netted with the value of shares withheld for taxes on the issuance of restricted stock units.

[3] Dollar amount includes an incremental amount related to the 1% excise tax on share repurchases.